0001062993-22-008679.txt : 20220325
0001062993-22-008679.hdr.sgml : 20220325
20220325190042
ACCESSION NUMBER: 0001062993-22-008679
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220323
FILED AS OF DATE: 20220325
DATE AS OF CHANGE: 20220325
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Brien James Michael
CENTRAL INDEX KEY: 0001632111
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40886
FILM NUMBER: 22772845
MAIL ADDRESS:
STREET 1: C/O ENZO BIOCHEM INC.
STREET 2: 527 MADISON AVE.
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COGNITION THERAPEUTICS INC
CENTRAL INDEX KEY: 0001455365
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2403 SIDNEY STREET
STREET 2: SUITE 261
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
BUSINESS PHONE: 412-481-2210
MAIL ADDRESS:
STREET 1: 2500 WESTCHESTER AVE
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: COGNITION THERAPUTICS INC
DATE OF NAME CHANGE: 20090204
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-03-23
0001455365
COGNITION THERAPEUTICS INC
CGTX
0001632111
O'Brien James Michael
C/O COGNITION THERAPEUTICS, INC.
2500 WESTCHESTER AVE.
PURCHASE
NY
10577
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
3.05
2022-03-23
4
A
0
50000
0
A
2032-03-23
Common Stock
50000
50000
D
The option vests 25% on March 23, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer on such vesting date.
/s/ James O'Brien
2022-03-25